Literature DB >> 23246038

Antigen presentation by Langerhans cells.

Botond Z Igyártó1, Daniel H Kaplan.   

Abstract

Langerhans cells and other skin-resident dendritic cells (DC) are required for the development of cutaneous adaptive immune responses. In vivo experiments using mice with selective DC-subset deficiencies and ex vivo experiments using isolated DC suggests that each subset makes a unique contribution to the adaptive response. This review focuses on the functional outcome of antigen presentation by Langerhans cells. Special attention is given to their ability to promote CD4 T cell differentiation in a variety of inflammatory contexts and whether this subset has the capacity to cross-prime CD8 T cells.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246038      PMCID: PMC3593958          DOI: 10.1016/j.coi.2012.11.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  37 in total

1.  Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization.

Authors:  Yukai He; Jiying Zhang; Cara Donahue; Louis D Falo
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

2.  Langerin expressing cells promote skin immune responses under defined conditions.

Authors:  Liangchun Wang; Laura S Bursch; Adrien Kissenpfennig; Bernard Malissen; Stephen C Jameson; Kristin A Hogquist
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 3.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

4.  Langerhans cells cross-present antigen derived from skin.

Authors:  Patrizia Stoitzner; Christoph H Tripp; Andreas Eberhart; Kylie M Price; Jae Y Jung; Laura Bursch; Franca Ronchese; Nikolaus Romani
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-03       Impact factor: 11.205

5.  Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells.

Authors:  Lidija Bosnjak; Monica Miranda-Saksena; David M Koelle; Ross A Boadle; Cheryl A Jones; Anthony L Cunningham
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

6.  Tumor immunotherapy by epicutaneous immunization requires langerhans cells.

Authors:  Patrizia Stoitzner; Laura K Green; Jae Y Jung; Kylie M Price; Christoph H Tripp; Bernard Malissen; Adrien Kissenpfennig; Ian F Hermans; Franca Ronchese
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

7.  Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo.

Authors:  Juliana Idoyaga; Cheolho Cheong; Koji Suda; Nao Suda; Jae Y Kim; Haekyung Lee; Chae Gyu Park; Ralph M Steinman
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

8.  Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes.

Authors:  Lisa A Nichols; Yiming Chen; Teresa A Colella; Clare L Bennett; Björn E Clausen; Victor H Engelhard
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

9.  Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells.

Authors:  N Romani; S Koide; M Crowley; M Witmer-Pack; A M Livingstone; C G Fathman; K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.

Authors:  G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

View more
  34 in total

Review 1.  The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells.

Authors:  William R Heath; Francis R Carbone
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

2.  Staphylococcus aureus toxin suppresses antigen-specific T cell responses.

Authors:  Brandon Lee; Reuben Olaniyi; Jakub M Kwiecinski; Juliane Bubeck Wardenburg
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

3.  EpCAM Expressed by Murine Epidermal Langerhans Cells Modulates Immunization to an Epicutaneously Applied Protein Antigen.

Authors:  Takeshi Ouchi; Gaku Nakato; Mark C Udey
Journal:  J Invest Dermatol       Date:  2016-04-19       Impact factor: 8.551

4.  Antigenic Hsp70-peptide upregulate altered cell surface MHC class I expression in TAMs and increases anti-tumor function in Dalton's lymphoma bearing mice.

Authors:  Pramod Kumar Gautam; Arbind Acharya
Journal:  Tumour Biol       Date:  2014-11-28

5.  Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells.

Authors:  Marija Zaric; Oksana Lyubomska; Candice Poux; Mary L Hanna; Maeliosa T McCrudden; Bernard Malissen; Rebecca J Ingram; Ultan F Power; Christopher J Scott; Ryan F Donnelly; Adrien Kissenpfennig
Journal:  J Invest Dermatol       Date:  2014-09-22       Impact factor: 8.551

6.  Regulation of contact sensitivity in non-obese diabetic (NOD) mice by innate immunity.

Authors:  Marian Szczepanik; Monika Majewska-Szczepanik; Florence S Wong; Paulina Kowalczyk; Chandrashekhar Pasare; Li Wen
Journal:  Contact Dermatitis       Date:  2018-06-25       Impact factor: 6.600

Review 7.  TGF-β1-induced transcription factor networks in Langerhans cell development and maintenance.

Authors:  X Zhang; J Gu; F-S Yu; L Zhou; Q-S Mi
Journal:  Allergy       Date:  2016-04-15       Impact factor: 13.146

8.  Regulation of T helper cell responses during antigen presentation by norepinephrine-exposed endothelial cells.

Authors:  Linghui Xu; Wanhong Ding; Lori L Stohl; Xi K Zhou; Shayan Azizi; Ethan Chuang; Jimmy Lam; John A Wagner; Richard D Granstein
Journal:  Immunology       Date:  2017-12-20       Impact factor: 7.397

9.  NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses.

Authors:  Maarten A Ligtenberg; Nicole Rojas-Colonelli; Rolf Kiessling; Alvaro Lladser
Journal:  Hum Vaccin Immunother       Date:  2013-07-24       Impact factor: 3.452

10.  Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.

Authors:  Nicholas A Siciliano; Adam R Hersperger; Aimee M Lacuanan; Ren-Huan Xu; John Sidney; Alessandro Sette; Luis J Sigal; Laurence C Eisenlohr
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.